Clinical Trial

Compassion, Social Support, Flexibility, and Resilience Program for Women Surviving Breast Cancer

Study acronym: ReACT
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated May 21, 2025 (before its estimated January 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to investigate the effects of an Acceptance and Commitment Therapy (ACT) based program (ReACT) to increase social support, compassion and psychological flexibility on psychological resilience in women undergoing mastectomy. The main question it aims to answer is: Does the ReACT program improve participants' resilience by increasing social support, compassion, and psychological flexibility? Researchers will compare intervention group to control group to see if ReACT program works to improve participants' resilience. Researchers will randomly divide participants into two groups: intervention group and control group. * Participants will complete some questionnaires. * Participants in the intervention group will join a 3-week ACT-based psychological flexibility program. This program consists of sessions that last 90 minutes each. The program adopts the core principles of ACT and aims to help participants develop skills in mindfulness, acceptance, value-driven living, and cognitive defusion. * Participants will complete the same questionnaires again after the program. * Participants will complete the same questionnaires again 1 month after the program ends.
Trial Details
NCT Number NCT06982391
Lead Sponsor Medipol University
Conditions Breast Cancer Survivor, Mastectomy
Enrollment 20 participants
Start Date 2025-04-12
Primary Completion 2026-01-15 (estimated)
Study Completion 2026-04-15 (estimated)
Updated on ClinicalTrials.gov 2025-05-21